The aim of this study was to assess and compare the efficacy of fractional CO2 laser, Q-switched Nd:YAG laser (1064 nm), and their combined use in treatment of keratosis pilaris. The study included twenty female patients. For each patient, three areas were randomly assigned to treatment by either fractional CO2 laser (area A) or Q-switched laser (1064 nm) (area C), or both types of laser (area B). All patients were assessed by digital photography at baseline and 1 month after the last session. Assessment was done by two non-blinded and two blinded investigators (blinded investigators do not know which area is treated with which machine and non-blinded knows). Patients reported the degree of satisfaction or any adverse effects also after 1 month from the last session. The three treatment modalities led to overall improvement in the KP lesions. According to patients’ score and investigator two, area B showed statistically significant improvement compared to areas A and C (p=0.001 and p=0.039, respectively). The first blinded investigators’ assessment revealed that there was statistically significant improvement in area C compared to A and B (p = 0.023). The assessment of both investigator one and the second blinded investigator revealed that there was improvement in the three areas with no statistically significant difference between them. Both fractional CO2 and Q-switched Nd:YAG laser (1064 nm) proved to be safe and effective in the treatment of keratosis pilaris regarding not only pigmentation but also follicular prominence; their combination may have an additive effect.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Lee NY, Ibrahim O, Khetarpal S et al (2018) Dermal microflora restoration with ammonia-oxidizing bacteria Nitrosomonas eutropha in the treatment of keratosis pilaris: a randomized clinical trial. Journal of drugs in dermatology 17(3):285–288
Wang JF and Orlow SJ (2018): Keratosis pilaris and its subtypes: associations, new molecular and pharmacologic etiologies, and therapeutic options. Am J Clin Dermatol 19(5):733–757
Hwang S, Schwartz RA (2008) Keratosis pilaris: a common follicular hyperkeratosis. Cutis 82(3):177–180
Gruber R, Sugarman JL, Crumrine D et al (2015) Sebaceous gland, hair shaft, and epidermal barrier abnormalities in keratosis pilaris with and without filaggrin deficiency. Am J Pathol 185(4):1012–1021
Vachiramon V, Anusaksathien P, Kanokrungsee S et al (2016) Fractional carbon dioxide laser for keratosis pilaris: a single-blind, randomized, comparative study. Biomed Res Int 3:1–6
Cameli N, Mariano M (2016) Complications of fractional lasers (ablative and non-ablative). In: Nonsurgical Lip and Eye Rejuvenation Techniques, vol 14. Springer, Cham, pp 117–123
Arora P, Sarkar R (2015) Lasers for Melasma. Melasma, A Monograph, p 66
Qin Y, Qin X, Xu P et al (2018) Potential role of S100A8 in skin rejuvenation with the 1064-nm Q-switched Nd: YAG laser (1064nm). Lasers Med Sci 33(3):581–588
Park J, Kim BJ, Kim MN et al (2011) A pilot study of Q-switched Nd:YAG laser (1064nm) treatment in the keratosis pilaris. Ann Dermatol 23(3):293–298
Chan YH (2003a) Biostatistics 103: qualitative data –tests of independence. Singap Med J 44(10):498–503
Chan YH (2003b) Biostatistics 104: correlational analysis. Singap Med J 44(12):614–619
Panchaprateep R, Tanus A, Tosti A (2015) Clinical, dermoscopic, and histopathologic features of body hair disorders. J Am Acad Dermatol 72(5):890–900
Yosipovitch G, Devore A, Dawn A (2007) Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dermatol 56(6):901–916
Tierney EP, Eisen RF, Hanke CW (2011) Fractionated CO2 laser skin rejuvenation. Dermatol Ther 24(1):41–53
Hantash BM, Bedi VP, Sudireddy V et al (2006) Laser-induced trans epidermal elimination of dermal content by fractional photothermolysis. J Biomed Opt 11:411–415
Katz TM, Goldberg LH, Firoz BF, Friedman PM (2009) Fractional photothermolysis for the treatment of postinflammatory hyperpigmentation. Dermatol Surg 35:1844–1848
Issler-Fisher AC, Waibel JS, Donelan MB (2017) Laser modulation of hypertrophic scars: technique and practice. Clin Plast Surg 44(4):757–766
Schmults CD, Phelps R, Goldberg DJ (2004) Nonablative facial remodeling: erythema reduction and histologic evidence of new collagen formation using a 300-microsecond 1064-nm Nd: YAG laser. Archives of Dermatology 140(11):1373–1376
Kim S (2011) Treatment of pigmented keratosis pilaris in Asian patients with a novel Q-switched Nd:YAG laser (1064) laser. Journal of Cosmetic and Laser Therapy 13(3):120–122
Ueda A (2014) Treatment of lichen pilaris with a Q-switched Nd:YAG laser (1064nm) in quasi long-pulsed mode: a case report. Laser Therapy 23(3):211–220
Conflict of interest
The authors declare that they have no conflict of interest.
This study is approved by the ethical committee.
All patients signed written consent.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sobhi, R.M., Adawy, N.A.H. & Zaky, I.S. “Comparative study between the efficacy of fractional CO2 laser, Q-switched Nd:YAG laser (1064 nm), and both types in treatment of keratosis pilaris”. Lasers Med Sci 35, 1367–1376 (2020). https://doi.org/10.1007/s10103-020-02956-w
- Keratosis pilaris
- Fractional CO2 laser
- Q-switched Nd:YAG laser (1064 nm)